Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -269.42% is 67% above its 5-year average of -825.10%, near the high end of its 5-year range (-33742.99%–38.73%).
28.92% above its 12-month average of -379.03%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -767.30%.
NET PROFIT MARGIN
-269.42%
NET PROFIT MARGIN AVG TTM
-379.03%
NET PROFIT MARGIN AVG 3Y
-323.09%
NET PROFIT MARGIN AVG 5Y
-825.10%
NET PROFIT MARGIN AVG 10Y
-372.77%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+28.92%
CURRENT VS 3Y AVG
+16.61%
CURRENT VS 5Y AVG
+67.35%
CURRENT VS 10Y AVG
+27.73%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 509 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Atara Biotherapeutics, Inc.
Market Cap
$84.61M
Net Profit Margin
-269.42%
TTM Avg
-379.03%
3Y Avg
-323.09%
5Y Avg
-825.10%
Market Cap
$84.17M
Net Profit Margin
-4560.82%
TTM Avg
-1001.79%
3Y Avg
-692.03%
5Y Avg
-1554.36%
Market Cap
$84.40M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$87.74M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$87.88M
Net Profit Margin
0.00%
TTM Avg
-9.81%
3Y Avg
-113.18%
5Y Avg
-75.45%
Market Cap
$88.17M
Net Profit Margin
6.21%
TTM Avg
8.02%
3Y Avg
-5.41%
5Y Avg
-4.66%
Market Cap
$88.21M
Net Profit Margin
2.57%
TTM Avg
-5.95%
3Y Avg
-14.59%
5Y Avg
-10.91%
Market Cap
$88.63M
Net Profit Margin
-7884.06%
TTM Avg
-7191.86%
3Y Avg
-8225.67%
5Y Avg
-7676.39%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | $84.61M | -269.42% | -379.03% | -323.09% | -825.10% |
| Humacyte, Inc. (HUMA)vs › | $84.17M | -4560.82% | -1001.79% | -692.03% | -1554.36% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.40M | 0.00% | 0.00% | 0.00% | 0.00% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $87.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| Equillium, Inc. (EQ)vs › | $87.88M | 0.00% | -9.81% | -113.18% | -75.45% |
| CareCloud, Inc. (CCLD)vs › | $88.17M | 6.21% | 8.02% | -5.41% | -4.66% |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 2.57% | -5.95% | -14.59% | -10.91% |
| Cardiff Oncology, Inc. (CRDF)vs › | $88.63M | -7884.06% | -7191.86% | -8225.67% | -7676.39% |
| Conexeu Sciences Inc. (CNXU)vs › | $89.11M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $79.78M | -648.32% | 0.00% | 0.00% | 0.00% |
Operating Margin
29.7%
Net Profit Margin
-269.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -767.30% |
| 2026-03-31 | -803.29% |
| 2025-12-31 | -213.54% |
| 2025-09-30 | -124.62% |
| 2025-06-30 | 13.58% |
| 2025-03-31 | 38.73% |
| 2024-12-31 | -38.75% |
| 2024-09-30 | -54.51% |
| 2024-06-30 | -66.51% |
| 2024-03-31 | -116.07% |
| 2023-12-31 | -1421.68% |
| 2023-09-30 | -3264.59% |
| 2023-06-30 | -7430.30% |
| 2023-03-31 | -6098.78% |
| 2022-12-31 | -33742.99% |
| 2022-09-30 | -1885.87% |
| 2022-06-30 | 35.80% |
| 2022-03-31 | -1204.61% |
| 2021-12-31 | -1236.74% |
| 2021-09-30 | -1576.61% |
| 2021-06-30 | -2165.19% |
| 2021-03-31 | -2205.38% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |